Intralaryngeal barriers to the spread of cancer.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMID 3618179)

Published in Acta Otolaryngol on September 11, 1987

Authors

J A Kirchner, D Carter

Articles citing this

Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx. Br J Cancer (1990) 0.96

Treatment of T1b glottic SCC: laser vs. radiation--a Canadian multicenter study. J Otolaryngol Head Neck Surg (2013) 0.91

The periepiglottic space: topographic relations and histological organisation. J Anat (1996) 0.89

Endoscopic supraglottic laryngectomy: a proposal for a classification by the working committee on nomenclature, European Laryngological Society. Eur Arch Otorhinolaryngol (2009) 0.89

Options for salvage after failed initial treatment of anterior vocal commissure squamous carcinoma. Eur Arch Otorhinolaryngol (2006) 0.80

The significance of pre-epiglottic space invasion in supraglottic laryngeal carcinomas. Eur Arch Otorhinolaryngol (1997) 0.79

Diagnosis of anterior commissure invasion in laryngeal cancer. Eur Arch Otorhinolaryngol (2009) 0.77

Cartilage invasion patterns in laryngeal cancer. Eur Arch Otorhinolaryngol (2015) 0.76

Borders and topographic relationships of the paraglottic space. Eur Arch Otorhinolaryngol (1997) 0.75

Functional organ preservation in laryngeal and hypopharyngeal cancer. GMS Curr Top Otorhinolaryngol Head Neck Surg (2012) 0.75

Transoral Laser Microsurgery in Early Glottic Lesions. Curr Otorhinolaryngol Rep (2017) 0.75

Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery. Clin Exp Otorhinolaryngol (2017) 0.75

Borders and topographic relations of the cricoid area. Eur Arch Otorhinolaryngol (1997) 0.75

Therapeutic modalities and oncologic outcomes in the treatment of T1b glottic squamous cell carcinoma: a systematic review. Eur Arch Otorhinolaryngol (2017) 0.75

Articles by these authors

(truncated to the top 100)

Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J Infect Dis (1997) 4.66

Insertional tagging, cloning, and expression of the Toxoplasma gondii hypoxanthine-xanthine-guanine phosphoribosyltransferase gene. Use as a selectable marker for stable transformation. J Biol Chem (1996) 4.06

Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N Engl J Med (1995) 3.92

Metastatic mature teratoma in lung following testicular embryonal carcinoma and teratocarcinoma. Arch Pathol Lab Med (1993) 2.16

Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis (1984) 2.11

BAG-1: a novel biomarker predicting long-term survival in early-stage breast cancer. J Clin Oncol (2001) 1.97

Margins of "lumpectomy" for breast cancer. Hum Pathol (1986) 1.86

Adenoid cystic carcinoma: a retrospective clinical review. Int J Cancer (2001) 1.83

Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res (1997) 1.76

Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts. MBio (2011) 1.76

Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance. Radiology (2000) 1.72

Crystal structures of Toxoplasma gondii HGXPRTase reveal the catalytic role of a long flexible loop. Nat Struct Biol (1996) 1.66

True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys (2000) 1.62

Calcifications in axillary lymph nodes caused by fat necrosis. AJR Am J Roentgenol (1996) 1.54

Intracystic papillary carcinoma of the breast. After mastectomy, radiotherapy or excisional biopsy alone. Cancer (1983) 1.53

Single cell analysis of cytokine gene coexpression during CD4+ T-cell phenotype development. Proc Natl Acad Sci U S A (1995) 1.51

Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi's sarcoma. J Natl Cancer Inst (1995) 1.46

Mass spectrometric identification of mtb81, a novel serological marker for tuberculosis. J Clin Microbiol (2000) 1.44

Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. Cancer Res (1998) 1.44

The nasogastric tube syndrome. Laryngoscope (1990) 1.43

Reproducibility of major diagnoses in a binational study of lung cancer in uranium miners and atomic bomb survivors. Am J Clin Pathol (1994) 1.42

The detection and treatment of early lung cancer. Ann Surg (1974) 1.39

Relationship between breast histopathology and family history of breast cancer. Cancer (1993) 1.38

Scar cancers of the lung: origin and significance. Hum Pathol (1984) 1.31

Articular reflex mechanisms in the larynx. Ann Otol Rhinol Laryngol (1965) 1.29

Breast carcinoma in situ: risk factors and screening patterns. J Natl Cancer Inst (2001) 1.26

Occult bronchogenic carcinoma. Endoscopic localization and television documentation. Cancer (1972) 1.26

Two hundred laryngeal cancers: patterns of growth and spread as seen in serial section. Laryngoscope (1977) 1.25

Risk of female breast cancer associated with serum polychlorinated biphenyls and 1,1-dichloro-2,2'-bis(p-chlorophenyl)ethylene. Cancer Epidemiol Biomarkers Prev (2000) 1.24

Ectopic pregnancy: duplex Doppler evaluation. Radiology (1989) 1.22

Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J Clin Oncol (2000) 1.19

Perceptions of academic vulnerability associated with personal illness: a study of 1,027 students at nine medical schools. Collaborative Research Group on Medical Student Health. Compr Psychiatry (2001) 1.18

Ovarian adenocarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1. Am J Pathol (1990) 1.18

Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer. Cancer Res (1998) 1.18

FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo and in vitro. Oncogene (1991) 1.18

Carcinoma in situ of the breast. Cancer (1977) 1.17

Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted? Radiology (2000) 1.15

Correlation of Doppler US tumor signals with neovascular morphologic features. Radiology (1988) 1.15

Primary malignant melanoma of the lower respiratory tract. Report of a case and literature review. Am J Clin Pathol (1990) 1.12

IgD antibody to insuin. Lancet (1970) 1.12

Search for resistances controlling canine gastric emptying of liquid meals. Am J Physiol (1981) 1.12

Heterotopic epithelium in axillary lymph nodes: report of a case and review of the literature. Am J Clin Pathol (1973) 1.11

Crystal structures of Toxoplasma gondii uracil phosphoribosyltransferase reveal the atomic basis of pyrimidine discrimination and prodrug binding. EMBO J (1998) 1.09

Neu proto-oncogene amplification and expression in ovarian adenocarcinoma cell lines. Am J Pathol (1992) 1.09

Biomechanical comparison of conventional open reduction and internal fixation versus calcium phosphate cement fixation of a central depressed tibial plateau fracture. J Orthop Trauma (2001) 1.06

Microsatellite instability in ovarian neoplasms. Br J Cancer (1995) 1.06

Pathology of carcinoma of the lung. Changing patterns. Clin Chest Med (1982) 1.05

Pathologic examination of major pulmonary specimens resected for neoplastic disease. Pathol Annu (1983) 1.05

Breast carcinoma tumor characteristics in black and white women. Cancer (1998) 1.05

Circulating levels of CSF-1 (M-CSF) a lymphohematopoietic cytokine may be a useful marker of disease status in patients with malignant ovarian neoplasms. Int J Radiat Oncol Biol Phys (1989) 1.04

Adjuvants for malaria vaccines. Parasite Immunol (2009) 1.04

The measurement of premenstrual mood symptoms. J Affect Disord (1999) 1.02

Benign mesothelial cells in mediastinal lymph nodes. Am J Surg Pathol (1999) 1.01

Comparison of rebiopsy rates after stereotactic core needle biopsy of the breast with 11-gauge vacuum suction probe versus 14-gauge needle and automatic gun. AJR Am J Roentgenol (1999) 1.01

Localization and targeting of the Leishmania donovani hypoxanthine-guanine phosphoribosyltransferase to the glycosome. J Biol Chem (1998) 1.01

Immunohistochemical evaluation of pleural mesothelioma and pulmonary adenocarcinoma. A bi-institutional study of 47 cases. Am J Surg Pathol (1987) 1.00

Vasopressin gene expression in the rodent hypothalamus: transcriptional and posttranscriptional responses to physiological stimulation. Mol Endocrinol (1990) 1.00

Five hundred cancers of the larynx and pyriform sinus. Results of treatment by radiation and surgery. Laryngoscope (1977) 1.00

High level expression of fms proto-oncogene mRNA is observed in clinically aggressive human endometrial adenocarcinomas. Int J Radiat Oncol Biol Phys (1988) 1.00

Pharmacological characterization of PF-00547659, an anti-human MAdCAM monoclonal antibody. Br J Pharmacol (2009) 0.99

Cleft larynx. Arch Otolaryngol (1967) 0.99

Conservative surgery and radiation therapy in breast carcinoma: local recurrence and prognostic implications. Int J Radiat Oncol Biol Phys (1989) 0.99

Vasopressin RNA in the neural lobe of the pituitary: dramatic accumulation in response to salt loading. Proc Natl Acad Sci U S A (1989) 0.98

Hunter's syndrome: a study in airway obstruction. Laryngoscope (1987) 0.98

Molecular determinants of peptide binding to two common rhesus macaque major histocompatibility complex class II molecules. J Virol (2001) 0.98

Detection of mammaglobin in the sera of patients with breast cancer. Tumour Biol (2002) 0.98

A clinical and histopathologic analysis of the results of conservation surgery and radiation therapy in stage I and II breast carcinoma. Cancer (1986) 0.98

Modulation of the mouse testis transcriptome during postnatal development and in selected models of male infertility. Mol Hum Reprod (2004) 0.98

Underestimation of breast cancer with II-gauge vacuum suction biopsy. AJR Am J Roentgenol (2000) 0.97

Histopathological features of hepatitis C in renal transplant candidates [see comment]. Transplantation (2000) 0.97

DDE and DDT in breast adipose tissue and risk of female breast cancer. Am J Epidemiol (1999) 0.96

Hypercalcemia in small cell carcinoma of the pancreas. Cancer (1984) 0.96

Human studies with the chelating agents, DMPS and DMSA. J Toxicol Clin Toxicol (1992) 0.96

Pathobiologic findings in DCIS of the breast: morphologic features, angiogenesis, HER-2/neu and hormone receptors. Exp Mol Pathol (2001) 0.96

A controlled study of light therapy in women with late luteal phase dysphoric disorder. Psychiatry Res (1999) 0.96

Transglottic cancer. Its growth and spread within the larynx. Arch Otolaryngol (1974) 0.95

One hundred laryngeal cancers studies by serial section. Ann Otol Rhinol Laryngol (1969) 0.95

The role of the microbial flora in uremia. II. Uremic colitis, cardiovascular lesions, and biochemical observations. J Exp Med (1966) 0.94

Mechanical and physiological properties of reflex laryngeal closure. Ann Otol Rhinol Laryngol (1972) 0.94

Intraductal papillary tumors of the breast: a study of 78 cases. Cancer (1977) 0.93

Angiosarcoma of the breast. Am J Surg Pathol (1983) 0.93

Functional assay for HER-2/neu demonstrates active signalling in a minority of HER-2/neu-overexpressing invasive human breast tumours. Br J Cancer (1996) 0.92

Benign clinical behavior of immature mediastinal teratoma in infancy and childhood: report of two cases and review of the literature. Cancer (1982) 0.91

Environmental sampling for Cryptococcus neoformans var. gattii from the Blue Mountains National Park, Sydney, Australia. Med Mycol (2002) 0.91

Benign mixed tumors (pleomorphic adenomas) of the breast. Am J Surg Pathol (1990) 0.91

Immunohistochemical characterization of a set of monoclonal antibodies to human neuron-specific enolase. Am J Pathol (1988) 0.91

Recombinant expression, purification, and characterization of Toxoplasma gondii adenosine kinase. Mol Biochem Parasitol (1999) 0.91

Afferent nerve fibers in the external branch of the superior larygneal nerve in the cat. Ann Otol Rhinol Laryngol (1968) 0.91

Molecular marker expression in oral and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (2001) 0.90

Effects of atropine and bethanechol on bombesin-stimulated release of pancreatic polypeptide and gastrin in dog. Gastroenterology (1979) 0.90

Vagal afferent influences on the phasic activity of the posterior cricoarytenoid muscle. Acta Otolaryngol (1973) 0.90

Visual loss in pseudotumor cerebri of childhood. A follow-up study. Arch Ophthalmol (1985) 0.90

Prognostic significance of colony-stimulating factor receptor expression in ipsilateral breast cancer recurrence. Clin Cancer Res (1998) 0.90

Vasopressin and oxytocin gene expression in rat testis. Endocrinology (1991) 0.89

Temporal monitoring of the nor-1 (aflD) gene of Aspergillus flavus in relation to aflatoxin B₁ production during storage of peanuts under different water activity levels. J Appl Microbiol (2010) 0.89

Cancer at the anterior commissure of the larynx. Results with radiotherapy. Arch Otolaryngol (1970) 0.89

Breast cancer risk associated with congeners of polychlorinated biphenyls. Am J Epidemiol (2000) 0.89

Small-cell carcinoma of the lung. Am J Surg Pathol (1983) 0.89

Lobular carcinoma of the breast an ultrastructural comparison with certain duct carcinomas and benign lesions. Johns Hopkins Med J (1969) 0.89

A system for providing surgical anesthesia for germfree rodents. J Appl Physiol (1965) 0.89